RYVVX
Price
$88.42
Change
+$0.16 (+0.18%)
Updated
Jul 3 closing price
Net Assets
8.58M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

RYVVX vs VVIAX

Header iconRYVVX vs VVIAX Comparison
Open Charts RYVVX vs VVIAXBanner chart's image
Rydex S&P 500 Pure Value C
Price$88.42
Change+$0.16 (+0.18%)
VolumeN/A
Net Assets8.58M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
RYVVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYVVX vs. VVIAX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. RYVVX (8.58M). VVIAX pays higher dividends than RYVVX: VVIAX (2.18) vs RYVVX (1.11). RYVVX was incepted earlier than VVIAX: RYVVX (21 years) vs VVIAX (25 years). RYVVX (2.34) is less costly to investors than VVIAX (0.05). RYVVX is a more actively managed with annual turnover of: 1099.00 vs. VVIAX (9.00). RYVVX has a lower initial minimum investment than VVIAX: RYVVX (2500) vs VVIAX (3000). RYVVX annual gain was more profitable for investors over the last year : 14.58 vs. VVIAX (12.03). RYVVX return over 5 years is better than : 101.84 vs. VVIAX (80.13).
RYVVXVVIAXRYVVX / VVIAX
Total Expense Ratio2.310.054,620%
Annual Report Gross Expense Ratio2.340.054,680%
Fund Existence21 years25 years-
Gain YTD5.8426.19894%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets8.58M189B0%
Annual Yield % from dividends1.112.1851%
Returns for 1 year14.5812.03121%
Returns for 3 years26.2535.1775%
Returns for 5 years101.8480.13127%
Returns for 10 years58.37115.6750%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.